An RNAi-Mediated Reduction in Transcription Factor Nrf-2 Blocks the Positive Effects of Dimethyl Fumarate on Metabolic Stress in Alzheimer’s Disease. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.